PDEX PRO DEX INC

MIXED Impact: 5/10 8-K
Horizon weeks Filed Apr 30, 2026 Processed 1mo ago SEC 0001079973-26-000581
8-K Item 2.02: Earnings release
Latest settled — T+20d
PDEX ▲ +38.40% at T+20d
NEUTRAL call ✓ call won +38.40% · α vs SPY +33.12% · entry $48.36 → $66.93
Next anchor: T+60d in 7w
Last close $65.00 (close Jun 8) · +34.41% from $48.36 entry
Entry anchored
Apr 30, 03:59 PM ET
via Databento tick
T+1d
+5.93%
call +5.93% · α +6.28%
$51.23
settled 6w ago
T+5d
+18.73%
call +18.73% · α +16.39%
$57.42
settled 5w ago
T+20d
+38.40%
call +38.40% · α +33.12%
$66.93
settled 12d ago
T+60d
call — · α —
in 7w

Price Chart

Loading chart...

Executive Summary

Pro-Dex reported record Q3 FY2026 revenue of $19.9M (+15% YoY), driven by next-gen handpiece shipments to its largest customer. However, operating income fell 15% to $3.1M due to a 41% surge in SG&A from the APM acquisition and non-recurring legal fees, while gross margin contracted 200bps to 31% on unfavorable product mix. Net income benefited from a $2.3M realized gain on Monogram CVRs, masking underlying operational pressure.

Key Financial Metrics

Gross Margin
30.7%

Actionable Insight

The record revenue headline is offset by deteriorating margins and rising costs from the APM integration. Watch the Q4 10-Q for operating expense normalization and margin recovery; the stock may trade on the revenue beat vs the operating income miss.

Key Facts

  • Q3 FY2026 revenue of $19.9M, a record quarterly high, up 15% YoY from $17.4M
  • Operating income declined 15% to $3.1M from $3.6M YoY due to 41% increase in operating expenses
  • Gross margin fell 200bps to 31% from 33% YoY, attributed to unfavorable product mix
  • Net income of $3.9M ($1.20 diluted) included a $2.3M realized gain from Monogram CVRs; adjusted net income would be ~$1.6M
  • Completed acquisition of Advanced Precision Machining (APM) during the quarter, adding $6.5M in goodwill and $712K in intangibles
  • Total debt increased to $18.5M from $15.4M at June 30, 2025, reflecting APM acquisition financing

Financial Impact

Revenue grew $2.5M YoY to a record $19.9M, but operating profit fell $546K. Net income was boosted by a $2.3M non-operating gain.

revenueoperating incomegross marginoperating expensesdebt

Risk Factors

  • Customer concentration risk — largest customer drives majority of revenue; legacy handpiece and repair revenue declining
  • Integration risk from APM acquisition — operating expenses rose 41% with non-recurring fees and continuing G&A costs
  • Gross margin compression — down 200bps YoY on product mix shift; may persist if next-gen handpiece carries lower margins
  • Elevated debt levels — total notes payable increased to $18.5M from $15.4M, increasing interest expense

Market Snapshot

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
86% bullish (7 analysts)

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001079973-26-000581
Document: pdex_8k.htm0001079973-26-000581
Document: 0001079973-26-000581-index-headers.html0001079973-26-000581
Document: 0001079973-26-000581-index.html0001079973-26-000581
Document: 0001079973-26-000581.txt0001079973-26-000581
8-K Data (Synthetic)0001079973-26-000581

US Market Status

Market Closed — Opens in 7h 22m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access